← Back to Search

All Patients: for Coronavirus (CAPTURE-2 Trial)

N/A
Waitlist Available
Led By Vicki Kalen
Research Sponsored by LumiraDx UK Limited
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights

CAPTURE-2 Trial Summary

This trial evaluates how well the LumiraDx SARS-CoV-2 Ab Test works compared to the reference method.

Eligible Conditions
  • Coronavirus

CAPTURE-2 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Performance Evaluation

CAPTURE-2 Trial Design

1Treatment groups
Experimental Treatment
Group I: All Patients:Experimental Treatment2 Interventions
Capillary and Venous Blood Collections

Find a Location

Who is running the clinical trial?

LumiraDx UK LimitedLead Sponsor
15 Previous Clinical Trials
34,337 Total Patients Enrolled
Vicki KalenPrincipal InvestigatorEclipse Clinical Research
William SimonPrincipal InvestigatorProfessional Research Network of Kansas
2 Previous Clinical Trials
2,200 Total Patients Enrolled

Media Library

Capillary Collection & Testing Clinical Trial Eligibility Overview. Trial Name: NCT04597047 — N/A
Coronavirus Research Study Groups: All Patients:
Coronavirus Clinical Trial 2023: Capillary Collection & Testing Highlights & Side Effects. Trial Name: NCT04597047 — N/A
Capillary Collection & Testing 2023 Treatment Timeline for Medical Study. Trial Name: NCT04597047 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experimental program open to new participants?

"Yes, as per the information posted on clinicaltrials.gov this medical trial is actively seeking participants. The initial posting was made on August 20th 2020 and most recently updated on October 20th 2020. In total 200 patients need to be recruited from 4 distinct sites for this study."

Answered by AI

To what extent is this investigation being administered across various sites?

"The research program is currently seeking participants at Physicians Quality Care of Jackson in Tennessee, Centura Health Physician Group's Northglenn Office in Colorado, Professional Research Network of Kansas in Wichita, and 4 additional sites."

Answered by AI

What is the current enrollment size of this research project?

"LumiraDx UK Limited is the study sponsor and they need 200 eligible patients to complete their trial. This will take place at Physicians Quality Care of Jackson in Tennessee and Centura Health Physician Group, Northglenn Office in Colorado."

Answered by AI
~33 spots leftby Mar 2025